Skip to main content

Day: August 24, 2020

CRCAM Alpes Provence : Déclarations_Hebdomadaires_CAAP_S34-2020

CAISSE REGIONALE DE CREDIT AGRICOLE MUTUEL ALPES PROVENCE                                                                                             Société coopérative à capital variable25, Chemin des trois cyprès 13097 Aix en Provence Cedex 2381 976 448 R.C.S Aix en ProvenceAix-en-Provence, le 24 août 2020Achats effectués dans les conditions de l’article 5 du règlement abus de marché dans le cadre du programme de rachat des Certificats Coopératifs d’Investissement autorisé par l’Assemblée Générale Mixte des sociétaires du 31 mars 2020.                                                                                             Le détail des transactions est disponible en annexe.Le Crédit Agricole Alpes Provence vous informe que le document est disponible sur son site Internet : http://www.ca-alpesprovence.fr et a été transmis...

Continue reading

District Court rules in favour of GrandVision

Claims made by EssilorLuxottica fully dismissedSchiphol, The Netherlands, 24 August 2020. Today, the District Court has in summary proceedings dismissed all claims made by EssilorLuxottica SA (Euronext: EL) to receive additional documentation mainly in relation to GrandVision NV’s (Euronext: GVNV) actions to mitigate the impact of COVID-19 on its business.The arbitration proceedings initiated by GrandVision against EssilorLuxottica, as communicated on 30 July 2020, are proceeding as planned. These proceedings are confidential and behind closed doors.GrandVision continues to support EssilorLuxottica with the shared objective to obtain regulatory approval for the closure of the Transaction within 12 to 24 months from the announcement date of 31 July 2019.AttachmentGrandVision Press Release 24 August

Continue reading

Reginn hf. – Uppgreiðsla skuldabréfaflokksins REG3A 14 1

Reginn atvinnuhúsnæði ehf., dótturfélag Regins hf. hefur nýtt sér ákvæði til uppgreiðslu skuldabréfaflokksins REG3A 14 1 og mun uppgjör fara fram 25. ágúst 2020. Uppgreiðslan er hluti af vegferð félagsins til endurfjármögnunar og er fjármögnuð með hagstæðu láni frá Íslandsbanka hf. sem færast mun undir almenna tryggingafyrirkomulag félagsins. Stefnt er að uppgreiðslu lánsins að undangengnu skuldabréfaútboði undir 70 ma.kr. útgáfuramma félagsins þegar markaðsaðstæður eru hagstæðar.Það er mat félagsins að á næstu misserum muni verða tækifæri til þess að nýta útgáfuramma félagsins til frekari fjármögnunar með skuldabréfaútgáfu. Fjármögnunin að baki skuldabréfaflokknum, sem nú er greiddur upp, bar 3,85 % vexti. Síðasta skuldabréfaútboð félagsins, útgáfa grænna skuldabréfa, var selt á kröfunni 2,5%.Nánari upplýsingar veitir:Helgi S. Gunnarsson...

Continue reading

Blue Vision A/S – Delårsrapportering 1. halvår 2020

Delårsrapportering 1. halvår 2020Selskabsmeddelelse nr.: 9Bestyrelsen for Blue Vision A/S har den 24. august 2020 behandlet og godkendt del-årsrapporten for perioden 1. januar – 30. juni 2020. Delårsregnskabet er ikke revideret eller reviewet af selskabets revisor.ResumeBlue Vision koncernen realiserede i perioden 1. januar – 30. juni 2020 et resultat efter skat på -12.241 tkr. (1. januar – 30. juni 2019: -3.074 tkr.). Selskabets egenkapital pr. 30. juni 2020 udgjorde 55.243 tkr. (30. juni 2019: 74.498 tkr.).Blue Vision´s datterselskaber Contra A/S og Aktiv Integration ApS har betydeligt reducerede aktiviteter. Derfor er der af forsigtighedshensyn hensat ekstraordinært tkr. 10.000 ligesom mellemregningen er nedskrevet med det fulde beløb for at imødekomme en eventuel afvikling af selskaberne.Blue Vision udsendte d. 28. november 2019 en...

Continue reading

SomaCeuticals Acquires License for Treatment of Multiple Sclerosis

Houston, TX, Aug. 24, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that the company’s subsidiary, SomaCeuticals, Inc., has executed a licensing agreement with 7 to Stand, Inc. (a Delaware corporation) for the exclusive global rights to U.S. patent 10,610,592 issued to Fabrizio de Silvestri, Terni, Italy, as inventor, April 7, 2020 for treatment of Multiple Sclerosis (MS).Multiple Sclerosis (MS) is a chronic disease in which the immune system of the individual attacks the central nervous system and affects the nerve cells. The disease can manifest with a wide range of neurological symptoms and can progress to total physical and cognitive disability. There are many different symptoms of MS, including fatigue, numbness, walking and balance problems,...

Continue reading

REG3A fjármögnun: Skuldabréfaflokkurinn REG3A 14 1

Með vísan til 2. kafla útgáfulýsingar skuldabréfaflokksins REG3A 14 1 (IS0000024313) og tilkynningar dags 24.07.2020, tilkynnist hér með að Reginn atvinnuhúsnæði ehf. hefur nýtt sér ákvæði til uppgreiðslu og hlutagreiðslu skv. lánssamningi við útgefanda og mun útgefandi inna sömu greiðslu af hendi inn á höfuðstól skuldabréfsins á næsta gjalddaga þess 25.08.2020. Reginn fyrirhugar að greiða lánssamninginn upp að fullu og mun því skuldabréfaflokkurinn REG3A 14 1 einnig vera greiddur upp að fullu á næsta gjalddaga þann 25.08.2020.Nánari upplýsingar veitir Þorkell Magnússon forstöðumaður skuldabréfa hjá Júpíter rekstrarfélagi hf. sem er rekstraraðili útgefanda.Sími: 854-1090Netfang: thorkell.magnusson@jupiter.is

Continue reading

Nemaska Lithium Accepts a Sale Proposal from Orion Mine Finance, Investissement Québec and The Pallinghurst Group

MONTREAL, Aug. 24, 2020 (GLOBE NEWSWIRE) — Nemaska ​​Lithium Inc. (“Nemaska Lithium” or the “Corporation”) announces today that it has accepted a sale proposal structured as a credit bid (the “Bid”) from a group (the “Buyers’ Group”) made up of the Corporation’s largest secured creditor, Orion Mine Finance (“Orion”), Investissement Québec and The Pallinghurst Group, acting through a new entity named Quebec Lithium Partners (The Pallinghurst Group collectively with Investissement Québec being hereinafter, the “Sponsors”), at the conclusion of its previously announced Sale or Investor Solicitation Process (the “SISP”) under the Companies’ Creditors Arrangement Act (the “CCAA”).After a thorough review, with its financial and legal advisors, of available qualified bids received as part of the SISP and after the withdrawal of other indications...

Continue reading

Nemaska Lithium accepte une proposition de vente de Orion Mine Finance, Investissement Québec et The Pallinghurst Group

MONTREAL, 24 août 2020 (GLOBE NEWSWIRE) — Nemaska Lithium Inc. (« Nemaska Lithium » ou la « Société ») annonce aujourd’hui qu’elle a accepté une proposition de vente structurée sous la forme d’une offre fondée sur la valeur des créances (credit bid) (l’« offre ») d’un groupe (le « groupe d’acheteurs ») constitué du plus grand créancier garanti de la Société, Orion Mine Finance (« Orion »), Investissement Québec et The Pallinghurst Group, agissant par l’entremise d’une nouvelle entité nommée Quebec Lithium Partners (The Pallinghurst Group et Investissement Québec étant ci-après collectivement désignés les « promoteurs ») à la conclusion de son processus de vente ou de sollicitation d’investisseurs préalablement annoncé (Sale & Investor Solicitation Process) (le « SISP ») en vertu de la Loi sur les arrangements avec les créanciers...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.